Actual Medicinal Product (AMP) Atrolak XL 200mg tablets (Accord-UK Ltd)
Stability Information
(Some stability information inherited from generic)
- Stability
-
Suitable for use in MCAs, although use is likely to be off-label. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
No stability data in MCAs available but no theoretical concerns with product.
- Provenance
-
This recommendation is based on the products Seroquel XL 200mg prolonged release tablets (Luye Pharma Limited) and Biquelle XL 200mg prolonged-release tablets (Aspire Pharma Ltd).
- Generic
- Quetiapine
- Formulation
- Quetiapine 200mg modified-release tablets
-
Quetiapine
-
Quetiapine 200mg modified-release tablets
-
Atrolak XL 200mg tablets (Accord-UK Ltd)
-
-
Quetiapine 25mg tablets
Quetiapine 400mg tablets